Abrdn Healthcare Investors (HQH)
NYSE: HQH · Real-Time Price · USD
19.18
0.00 (0.00%)
At close: Dec 23, 2025, 4:00 PM EST
19.18
0.00 (0.00%)
After-hours: Dec 23, 2025, 7:00 PM EST
HQH Revenue
In the fiscal year ending September 30, 2025, Abrdn Healthcare Investors had annual revenue of $7.53M, down -30.05%. Abrdn Healthcare Investors had revenue of $2.80M in the half year ending September 30, 2025, a decrease of -39.95%.
Revenue (ttm)
$7.53M
Revenue Growth
-30.05%
P/S Ratio
141.33
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 7.53M | -3.24M | -30.05% |
| Sep 30, 2024 | 10.77M | 477.43K | 4.64% |
| Sep 30, 2023 | 10.29M | 2.02M | 24.44% |
| Sep 30, 2022 | 8.27M | 1.79M | 27.63% |
| Sep 30, 2021 | 6.48M | -2.45M | -27.46% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionHQH News
- 8 days ago - 4 Closed-End Fund Buys In The Month Of November 2025 - Seeking Alpha
- 9 days ago - The Flavor Of Resilience: Why Essential Sectors Still Deliver; Yields +11% - Seeking Alpha
- 5 weeks ago - HQH: Seeing Strong Recent Returns While Attractively Discounted - Seeking Alpha
- 6 weeks ago - HQH: Severely Underperforms Peers (Rating Downgrade) - Seeking Alpha
- 2 months ago - Yes, You Can Retire On Dividends - Start Now! - Seeking Alpha
- 4 months ago - HQH: Income Approach To Play Healthcare Recovery - Seeking Alpha
- 4 months ago - Bank On Healthcare And An Aging Population With 14% Yield: HQH - Seeking Alpha
- 6 months ago - High Risk, Low Return: The Problem With HQH's Biotech Tilt - Seeking Alpha